Efficacy and Safety of Maribavir Dosed at 100 mg Orally Twice Daily for the Prevention of Cytomegalovirus Disease in Liver Transplant Recipients: A Randomized, Double-Blind, Multicenter Controlled Trial-Reference-Cited by-同舟云学术

Efficacy and Safety of Maribavir Dosed at 100 mg Orally Twice Daily for the Prevention of Cytomegalovirus Disease in Liver Transplant Recipients: A Randomized, Double-Blind, Multicenter Controlled Trial

Published:2012-09-04 Issue:11 Volume:12 Page:3021-3030
ISSN:1600-6135
Container-title:American Journal of Transplantation
language:en
Short-container-title:

Author:

Winston D. J.,Saliba F.,Blumberg E.,Abouljoud M.,Garcia-Diaz J. B.,Goss J. A.,Clough L.,Avery R.,Limaye A. P.,Ericzon B. G.,Navasa M.,Troisi R. I.,Chen H.,Villano S. A.,Uknis M. E.,

Publisher

Wiley

Subject

Pharmacology (medical),Transplantation,Immunology and Allergy

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1600-6143.2012.04231.x/fullpdf

Reference26 articles.

1. Cytomegalovirus infection after liver transplantation. Current concepts and challenges;Razonable;World J Gastroenterol,2008

2. Association of cytomegalovirus infection and disease with death and graft loss after liver transplant in high-risk recipients;Bosch;Am J Transplant,2011

3. Cytomegalovirus infection after liver transplantation using different prophylaxes;Kornberg;Transplant Proc,2001

4. Delayed onset primary cytomegalovirus disease after liver transplantation;Arthurs;Liver Transplant,2007

5. Randomized trial of efficacy and safety of oral ganciclovir in the prevention of cytomegalovirus disease in liver-transplant recipients. The Oral Ganciclovir International Transplantation Study Group;Gane;Lancet,1997

Cited by 122 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A Randomized Controlled Trial Comparing the Tolerability and Efficacy of Maribavir vs. Valganciclovir for CMV Prophylaxis in High-Risk Kidney Transplant Recipients: Study Protocol (Maribavir IIR);2024-09-04

2. Efficacy of the drug maribavir according to clinical studies;Clinical Medicine (Russian Journal);2024-05-07

3. Antiviral medications for preventing cytomegalovirus disease in solid organ transplant recipients;Cochrane Database of Systematic Reviews;2024-05-03

4. Prevention and management of cytomegalovirus infection and disease in kidney transplant: A consensus statement of the Transplantation Society of Taiwan;Journal of the Formosan Medical Association;2024-05

5. Advances in pharmacotherapies for cytomegalovirus infection: what is the current state of play?;Expert Opinion on Pharmacotherapy;2024-04-12